Right time to take profit off the table in pharma ; defence a structural buy : Rajiv (...)
Rajiv Batra addresses global investors' concerns about India's growth and policy, emphasizing the need for double-digit earnings and nominal GDP growth to reignite foreign investor interest. He suggests profit-taking in pharma due to US generic concerns and underwhelming earnings. Batra remains (...)
Site référencé: The Economic Times
The Economic Times
Can betting on last year's losers lead to higher stock market returns ?
22/08/2025
Sebi proposes regulation of grey market for unlisted companies to enhance price discovery and tax revenue
22/08/2025
Sebi plans to increase tenure, maturity of equity derivatives
22/08/2025
Punching error in block deal sparks sharp swings in Clean Science shares
22/08/2025
RBI defends 4% inflation target, seeks views on possible tweaks
21/08/2025
Clean Science bulk deal : Norges Bank picks Rs 158 crore stake. Nippon, SBI MF among buyers
21/08/2025
